Gene: PSMB10
Official Full Name: proteasome 20S subunit beta 10provided by HGNC
Gene Summary: The proteasome is a multicatalytic proteinase complex with a highly ordered ring-shaped 20S core structure. The core structure is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. This gene encodes a member of the proteasome B-type family, also known as the T1B family, that is a 20S core beta subunit. Proteolytic processing is required to generate a mature subunit. Expression of this gene is induced by gamma interferon, and this gene product replaces catalytic subunit 2 (proteasome beta 7 subunit) in the immunoproteasome. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO05515 | PSMB10 Knockout cell line (HeLa) | Human | PSMB10 | 1:3~1:6 | Negative | Online Inquiry |
KO05516 | PSMB10 Knockout cell line (HCT 116) | Human | PSMB10 | 1:2~1:4 | Negative | Online Inquiry |
KO05517 | PSMB10 Knockout cell line (HEK293) | Human | PSMB10 | 1:3~1:6 | Negative | Online Inquiry |
KO05518 | PSMB10 Knockout cell line (A549) | Human | PSMB10 | 1:3~1:4 | Negative | Online Inquiry |
PSMB10 Gene Knockout Cell Lines are genetically engineered cells in which the PSMB10 gene has been deliberately disrupted or rendered inactive. This specific gene encodes a core component of the proteasome complex, crucial for the intracellular degradation of ubiquitinated proteins. By knocking out PSMB10, these cell lines serve as valuable tools for researchers investigating protein degradation pathways, cellular responses to stress, and the roles of proteasome activity in various disease states.
The key function of PSMB10 Gene Knockout Cell Lines hinges on their ability to model conditions of proteasome dysfunction. This allows for detailed investigation into how altered proteasome activity influences cell survival, proliferation, and differentiation. Mechanistically, the loss of PSMB10 disrupts substrate degradation within the proteasome, leading to the accumulation of specific regulatory proteins that can profoundly affect signaling pathways associated with cancer, neurodegenerative diseases, and autoimmune disorders.
The scientific importance of these cell lines cannot be overstated; they provide an essential platform for drug discovery, mechanistic studies of proteasome inhibitors, and the development of novel therapeutic strategies aimed at restoring proteasome function. In clinical research, understanding the implications of PSMB10 knockout can enhance our knowledge of disease progression and potential therapeutic interventions.
Compared to alternative models, PSMB10 Gene Knockout Cell Lines offer enhanced specificity for studying the proteasome's role in metabolism and disease, thereby minimizing off-target effects common in less defined genetic models. They present a straightforward approach to elucidating the complex biology behind proteasome-associated processes, making them invaluable for both basic and translational research.
For researchers and clinicians alike, the adoption of PSMB10 Gene Knockout Cell Lines translates into more reliable data and a deeper understanding of cellular mechanisms, enhancing the potential for groundbreaking discoveries. Our company brings years of expertise in developing genetically modified cell lines and ensuring they meet the highest standards of quality and reliability, which empowers scientists to push the boundaries of biological research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.